New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab
© 2021 British Association of Dermatologists..
Our study sought to describe ocular surface alterations at baseline and after 4 months of dupilumab treatment in patients with severe AD. Our findings highlight that all 25 patients showed ocular surface alterations prior to dupilumab treatment. Dupilumab may cause the worsening of clinical or subclinical pre-existing ocular alterations belonging to the spectrum of AKC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:186 |
|---|---|
| Enthalten in: |
The British journal of dermatology - 186(2022), 1 vom: 27. Jan., Seite 186-187 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bortoluzzi, P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.03.2022 Date Revised 03.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjd.20706 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329747193 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329747193 | ||
| 003 | DE-627 | ||
| 005 | 20231225205808.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjd.20706 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1099.xml |
| 035 | |a (DE-627)NLM329747193 | ||
| 035 | |a (NLM)34431510 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bortoluzzi, P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.03.2022 | ||
| 500 | |a Date Revised 03.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 British Association of Dermatologists. | ||
| 520 | |a Our study sought to describe ocular surface alterations at baseline and after 4 months of dupilumab treatment in patients with severe AD. Our findings highlight that all 25 patients showed ocular surface alterations prior to dupilumab treatment. Dupilumab may cause the worsening of clinical or subclinical pre-existing ocular alterations belonging to the spectrum of AKC | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a dupilumab |2 NLM | |
| 650 | 7 | |a 420K487FSG |2 NLM | |
| 700 | 1 | |a Ferrucci, S |e verfasserin |4 aut | |
| 700 | 1 | |a Galimberti, D |e verfasserin |4 aut | |
| 700 | 1 | |a Garavelli, F |e verfasserin |4 aut | |
| 700 | 1 | |a Pozzo Giuffrida, F |e verfasserin |4 aut | |
| 700 | 1 | |a Pizzati, A |e verfasserin |4 aut | |
| 700 | 1 | |a Marzano, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Mapelli, C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of dermatology |d 1951 |g 186(2022), 1 vom: 27. Jan., Seite 186-187 |w (DE-627)NLM000000361 |x 1365-2133 |7 nnns |
| 773 | 1 | 8 | |g volume:186 |g year:2022 |g number:1 |g day:27 |g month:01 |g pages:186-187 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjd.20706 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 186 |j 2022 |e 1 |b 27 |c 01 |h 186-187 | ||